A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 623-628

  Todo, Yukiharu ^a   Okamoto, Kazuhira ^b   Hayashi, Masaru ^c   Minobe, Shinichiro ^d   Nomura, Eiji ^e   Hareyama, Hitoshi ^f   Takeda, Mahito ^a   Ebina, Yasuhiko ^a   Watari, Hidemichi ^a   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Asahikawa Kosei Hospital   (Japan)

^c Obihiro Kosei Hospital   (Japan)

^d Kushiro Red Cross Hospital   (Japan)

^e Oji General Hospital   (Japan)

^f SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

CA125; Endometrial carcinoma; Lymph node metastasis; MRI

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT INDICATION; TUMOR VOLUME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33846928494     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.002     Document Type: Article

References (11)

1. DiSaia P.J., Creasman W.T., Boronow R.C., and Blessing J.A. Risk factors and recurrent patterns in stage I endometrial carcinoma. Am. J. Obstet. Gynecol. 151 (1985) 1009-1015
2. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G., and Podratz K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am. J. Obstet. Gynecol. 182 (2000) 1506-1519
3. Mariani A., Webb M.J., Galli L., and Podratz K.C. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol. Oncol. 76 (2000) 348-356
4. Todo Y., Sakuragi N., Nishida R., Yamada T., Ebina Y., Yamamoto R., et al. Combined use of magnetic resonance imaging, CA125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am. J. Obstet. Gynecol. 188 (2003) 1265-1272
5. Sergio P. FIGO annual report on the results of treatment in gynaecological cancer, carcinoma of the corpus uteri. J. Epidemiol. Biostat. 6 (2001) 48-88
6. Orr Jr. J.W., Roland P.Y., Leichter D., and Orr P.F. Endometrial cancer: is surgical staging necessary?. Curr. Opin. Oncol. 13 (2001) 408-412
7. Hricak H., Rubinstein L.V., Gherman G.M., and Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179 (1991) 829-832
8. Kucera E., Kainz C., Reinthaller A., Sliutz G., Leodolter S., Kucera H., et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol. Obstet. Invest. 49 (2000) 62-66
9. Kayikcioglu F., Boran N., Meydanli M.M., Tulunay G., Kose F.M., and Bulbul D. Is frozen-section diagnosis a reliable guide in surgical treatment of stage I endometrial carcinoma?. Acta Oncol. 41 (2002) 444-446
10. Larson D.M., Johnson K.K., Broste S.K., Krawisz B.R., and Kresl J.J. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet. Gynecol. 86 (1995) 38-42
11. Panici P.B., and Angiolo R. Role of lymphadenectomy in ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 16 (2002) 529-551